Mwanzo002773 • SHE
add
Chengdu Kanghong Pharma Grp Co Ltd
Bei iliyotangulia
¥ 19.05
Bei za siku
¥ 18.79 - ¥ 19.07
Bei za mwaka
¥ 13.15 - ¥ 24.50
Thamani ya kampuni katika soko
17.10B CNY
Wastani wa hisa zilizouzwa
5.73M
Uwiano wa bei na mapato
14.63
Mgao wa faida
2.00%
Ubadilishanaji wa msingi
SHE
Habari za soko
The Straits Times
siku 1 iliyopita
Nasdaq closes lower, S&P 500 up slightly as US yields stay elevated
1.91%
1.08%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.12B | 3.59% |
Matumizi ya uendeshaji wa biashara | 673.79M | 8.73% |
Mapato halisi | 281.49M | -6.18% |
Kiwango cha faida halisi | 25.20 | -9.42% |
Mapato kwa kila hisa | — | — |
EBITDA | 388.25M | 0.77% |
Asilimia ya kodi ya mapato | 13.25% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 5.55B | 23.31% |
Jumla ya mali | 9.21B | 9.78% |
Jumla ya dhima | 778.25M | -2.32% |
Jumla ya hisa | 8.43B | — |
hisa zilizosalia | 919.78M | — |
Uwiano wa bei na thamani | 2.08 | — |
Faida inayotokana na mali | 9.20% | — |
Faida inayotokana mtaji | 10.03% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 281.49M | -6.18% |
Pesa kutokana na shughuli | 449.45M | -0.12% |
Pesa kutokana na uwekezaji | -141.02M | 84.66% |
Pesa kutokana na ufadhili | 6.59M | -26.54% |
Mabadiliko halisi ya pesa taslimu | 314.58M | 168.35% |
Mtiririko huru wa pesa | 149.61M | -2.28% |
Kuhusu
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion.
As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
Ilianzishwa
3 Okt 1996
Tovuti
Wafanyakazi
4,289
